| Patents for C07D 207 - Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom (40,304) |
|---|
| 06/01/2005 | EP1534704A1 Process for preparing 5-(4-fluorophenyl)-1-[2-((2r,4r)-4-hydroxy -6-oxo-tetrahydro-pyran-2-yl)ethyl]-2-isopropyl-4-phenyl-1h-pyrrole-3-carboxylic acid phenylamide |
| 06/01/2005 | EP1534693A2 1, 3-diamino-2-hydroxypropane prodrug derivatives |
| 06/01/2005 | EP1534689A1 Novel carboxamide compounds having an mch-antagonistic effect, medicaments containing said compounds, and methods for the production thereof |
| 06/01/2005 | EP1534678A1 Pleuromutilin derivatives as antimicrobbials |
| 06/01/2005 | EP1534671A2 Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds |
| 06/01/2005 | EP1534658A2 Ketone ligands for modulating the expression of exogenous genes via an ecdysone receptor complex |
| 06/01/2005 | EP1534334A1 Releasable polymeric conjugates based on aliphatic biodegradable linkers |
| 06/01/2005 | EP1534273A2 Modulators of the glucocorticoid receptor and method |
| 06/01/2005 | EP1534267A1 Pyrrolidine derivatives as tryptase inhibitors |
| 06/01/2005 | EP1392706B1 Olefin polymerization catalysts containing a pyrrole bisimine ligand |
| 06/01/2005 | EP1351959B1 Novel pleuromutilin derivatives |
| 06/01/2005 | EP1345902B1 Substituted heterocyclo-norbornylamine derivatives, method for producing the same, their use as medicament or diagnostic agent and medicament containing the same |
| 06/01/2005 | EP1254136A4 FACTOR Xa INHIBITORS WITH ARYL-AMIDINES AND DERIVATIVES, AND PRODRUGS THEREOF |
| 06/01/2005 | EP1115695B1 (r)-chiral halogenated 1-substitutedamino-(n+1)-alkanols useful for inhibiting cholesteryl ester transfer protein activity |
| 06/01/2005 | EP1095015B1 Sulfonylamino carboxylic acid n-arylamides as guanylate cyclase activators |
| 06/01/2005 | EP0994862B1 Sulphonamide derivatives being 5-ht6 receptor antagonists and process for their preparation |
| 06/01/2005 | CN1622942A HIV protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis |
| 06/01/2005 | CN1622941A Glutaminyl based DPIV inhibitors |
| 06/01/2005 | CN1621404A Drug and method for regulating cholesterol and triglyceride |
| 06/01/2005 | CN1621403A 2-(2-aminoethyl)methyl-pyrrolidine and preparation process thereof |
| 06/01/2005 | CN1204159C Reactive catalyst compositions for improving water blown polyurethane foam performance |
| 06/01/2005 | CN1204120C Three-position substituted pyrrole derivative and preparation process thereof |
| 05/31/2005 | US6900347 Reduced production of unwanted byproducts; purity, efficiency |
| 05/31/2005 | US6900345 Antibiotics; mutilin 14-[N-(2-carbamoyloxyethoxycarbonyl)]carbamate; therapy for bacteria infections; chemical synthesis |
| 05/31/2005 | US6900337 Production of 5-methyl-1-hydrocarbyl-2-pyrrolidone by reductive amination of levulinic acid |
| 05/31/2005 | US6900336 8-aza-11-deoxy prostaglandin analogues |
| 05/31/2005 | US6900322 Method for stereochemically controlled production of isomerically pure highly substituted azacyclic compounds |
| 05/31/2005 | US6900319 Carbo- and heterocyclic amidines |
| 05/31/2005 | US6900278 Ligands, complex compounds and their use for polymerising olefins |
| 05/31/2005 | US6900244 Controlling lipid, cholesterol metabolism; anticholesterol agents |
| 05/31/2005 | US6900238 HIV protease inhibitors |
| 05/31/2005 | US6900218 Reducing oxidation stresses; central nervous system disorders; antiinflammatory agents |
| 05/31/2005 | US6900213 Controlling fertility; contraceptives; anticancer agents |
| 05/31/2005 | US6900196 Serine protease inhibitors |
| 05/31/2005 | US6900192 Bile-acid conjugates for providing sustained systemic concentrations of drugs |
| 05/26/2005 | WO2005047906A1 Methods for monitoring il-18 |
| 05/26/2005 | WO2005047251A1 Melanocortin receptor agonists |
| 05/26/2005 | WO2005047250A1 N-acylated-3- (benzoyl) - pyrrolidines as 11-beta-hsd1 inhibitors useful for the treatment of metabolic disorders. |
| 05/26/2005 | WO2005047249A1 Benzylether amine compounds useful as ccr-5 antagonists |
| 05/26/2005 | WO2005046683A1 Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the same |
| 05/26/2005 | WO2005046676A1 Treatment or prevention of cardiovascular and respiratory disorders with novel substituted cyclic amp-specific phosphodiesterase inhibitors |
| 05/26/2005 | WO2005046599A2 Alpha, beta-unsaturated sulfoxides for treating proliferative disorders |
| 05/26/2005 | WO2005019168A8 Fluorinated lysine derivatives as dipeptidyl peptidase iv inhibitors |
| 05/26/2005 | WO2004078718A8 Compounds having activity at 5ht2c receptor and uses thereof |
| 05/26/2005 | US20050113520 used in optical telecommunications devices such as waveguides; monomers such as 2,4,6-tris(4-ethenyl-2,3,5,6-tetrafluorophenyl)-1,3,5-triazine |
| 05/26/2005 | US20050113450 method of sterilization, sanitation, antisepsis, and disinfection, includes applying antimicrobial compounds to a surface; e.g. 2-[(3-{[4-chloro(methyl)anilino]sulfonyl}benzoyl)amino]-5-(trifluoromethyl)benzoic acid |
| 05/26/2005 | US20050113424 E.g., 4-{3-[4-(3-{4-[amino(imino)methyl]phenoxy}propyl)-1-piperazinyl]propoxy}benzamidine; an antifungal agent with good pharmacokinetics and excellent antifungal action; side effect reduction such as nephrotoxicity; action to Mycomycetes |
| 05/26/2005 | US20050113415 Promoting the activity of glucocerebrosidease by administering a reversible competitive inhibitor such as iminosugars, e.g. calysegnines, isofagomines,N-alkyl-deoxynojirimycins; lysosomal storage disorders |
| 05/26/2005 | US20050113373 medicine to inhibit proliferative conditions, such as cancer and psoriasis; detecting or identifying a histone deactylase (HDAC) in a biological sample |
| 05/26/2005 | US20050113372 Therapy for ischemic-repefusion injuries; liver disorders; antiarrhythmia agents; anticancer agents; astaxanthin |
| 05/26/2005 | US20050113366 Derivatives of 4-hydroxybutanoic acid and of its higher homologue as ligands of $g(g)-hydroxybutyrate (ghb) receptors, pharmaceutical compositions containing same and pharmaceutical uses |
| 05/26/2005 | US20050113344 Substituted cyclic hydroxamates as inhibitors of matrix metalloproteinases |
| 05/26/2005 | US20050112672 Immobilization of compounds with connector groups of amines |
| 05/26/2005 | US20050112494 Bottom antireflective coatings |
| 05/26/2005 | US20050112406 Organometallic complexes and organic electroluminescence device using the same |
| 05/26/2005 | US20050112400 Complex containing organometallic compound |
| 05/26/2005 | CA2602772A1 Heterocyclic boronic acid compounds |
| 05/26/2005 | CA2545733A1 Methods for monitoring il-18 |
| 05/26/2005 | CA2543913A1 Benzylether amine compounds useful as ccr-5 antagonists |
| 05/26/2005 | CA2541949A1 Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the same |
| 05/26/2005 | CA2534342A1 Amino acid prodrugs |
| 05/25/2005 | EP1533298A1 3-aminopyrrolidone derivatives |
| 05/25/2005 | EP1532159A2 Scaffolded maleimide clusters for multivalent peptide assembly |
| 05/25/2005 | EP1532128A1 Inhibitors of hcv ns5b polymerase |
| 05/25/2005 | EP1532109A1 Pyrrolidine derivatives as oxytocin antagonists |
| 05/25/2005 | EP1532108A2 Structural carotenoid analogs for the inhibition and amelioration of disease |
| 05/25/2005 | EP1531818A1 Topical treatment of skin diseases |
| 05/25/2005 | EP1140814B1 Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds |
| 05/25/2005 | CN1620434A Pyrrolidine-2-ones as factor Xa inhibitors |
| 05/25/2005 | CN1620433A Pyrrolidine derivatives as inhibitors of endothelin-converting enzyme |
| 05/25/2005 | CN1618790A New Optical active derivative of flavo acidamide, its preparation method and its medicinal composition and use |
| 05/25/2005 | CN1203047C Biaryl ether derivatives useful as monoamine reuptake inhibitors |
| 05/24/2005 | US6897338 Treating biomass containing a polyhydroxyalkanoate to form an alkenoic acid |
| 05/24/2005 | US6897331 Fluorous triphase and other multiphase systems |
| 05/24/2005 | US6897323 Highly enantiomerically pure lactam-substituted propanoic acid derivatives and methods of making and using same |
| 05/24/2005 | US6897240 Thio semicarbazone and semicarbazone inhibitors of cysteine proteases and methods of their use |
| 05/24/2005 | US6897234 Asthma therapy; antiallergens; antiinflammatory agents |
| 05/24/2005 | US6897233 Enzyme inhibitors, a 2-oxopyrrolidin-3-yl-N-hydroxyacetamide derivatives; bactericides |
| 05/24/2005 | US6897210 Anticancer agents; antiarthritic agents |
| 05/19/2005 | WO2005044795A1 Process for the preparation of ccr-2 antagonist |
| 05/19/2005 | WO2005044791A2 2-halogen-6-alkyl-phenyl-substituted tetramic acid derivatives |
| 05/19/2005 | WO2005044785A1 Aralkyl amines as cannabinoid receptor modulators |
| 05/19/2005 | WO2005044195A2 Fused phenylalanine derivatives as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes |
| 05/19/2005 | WO2005012220A9 Cycloalkylidene compounds as modulators of estrogen receptor |
| 05/19/2005 | US20050107616 Alpha-ketoamide derivatives as cathepsin k inhibitors |
| 05/19/2005 | US20050107615 Immobilization of compounds with connector groups of amines |
| 05/19/2005 | US20050107543 Fluoro linkers and their use as linkers for enzyme-activated drug conjugates |
| 05/19/2005 | US20050107462 Methods for the preparation of pyrrolotriazine compounds useful as kinase inhibitors |
| 05/19/2005 | US20050107444 E.g., 2-(3-{3-[(2-chloro-3-(trifluoromethyl)-benzyl)-(2,2-diphenylethyl)-amino]-propoxy}phenyl)-1-morpholin-4-yl-ethanone; agonists of the nuclear receptors, LXR alpha and LXR beta used to increase ABCA1, ABCG1, and apolipoprotein E expression and inhibiting cholesterol absorption |
| 05/19/2005 | US20050107434 heterocyclic amines such as 1-Cyclopentyl-4-{2-[5-(4-methanesulfonylphenyl)[1,2,4]oxadiazol-3-yl]ethyl}piperidine and salts, used as histamine-H3 receptor antagonists for treatment of nervous system, cardiovascular , respiratory system, gastrointestinal system and endocrinological system disorders |
| 05/19/2005 | US20050107384 to inhibit proliferative conditions, such as cancer and psoriasis; detecting or identifying a HDAC in a biological sample comprising detecting or measuring the formation of a complex between a labelled compound as defined in claim (I) and a HDAC |
| 05/19/2005 | US20050107379 antithrombolytic agents such as (E)-2-(5-Chlorothien-2-yl)-N-{(3S)-1-[(1S)-1-methyl-2-morpholin-4-yl-2-oxoethyl]-2-oxopyrrolidin-3-yl}ethenesulfonamide, used for therapy of cardiovascular disorders |
| 05/19/2005 | US20050107370 Pyrrole derivatives as antimycobacterial compounds |
| 05/19/2005 | US20050107355 Agonists of the kappa opioid receptor for treating gastrointestinal disorders, pain, and pruritus; N-{2-[(S)-3-hydroxy-pyrrolidin-1-yl]-(S)-1-phenyl-ethyl}-N-methyl-2-phenylamino-acetamide |
| 05/19/2005 | US20050107334 Acyloxyalkyl carbamate prodrugs, methods of synthesis and use |
| 05/19/2005 | US20050106709 First reactive functional group used to provide attachment to a surface of a substrate, second reactive functional group is a N-sulfonyldicarboximide group reacted with an amine-containing material, to form a connector group between the substrate and amine containing material (protein, peptide, dna rna) |
| 05/19/2005 | DE10348044A1 Duale Alanyl-Aminopeptidase- und Dipeptidylpeptidase IV-Inhibitoren zur funktionellen Beeinflussung unterschiedlicher Zellen und zur Behandlung immunologischer, entzündlicher, neuronaler und anderer Erkrankungen Dual-alanyl aminopeptidase and dipeptidyl peptidase IV inhibitors for the functional influence of different cells and for the treatment of immunological, inflammatory, neuronal and other diseases |
| 05/19/2005 | DE10348023A1 Neue Alanyl-Aminopeptidasen-Inhibitoren zur funktionellen Beeinflussung unterschiedlicher Zellen und zur Behandlung immunologischer, entzündlicher, neuronaler und anderer Erkrankungen New alanyl aminopeptidase inhibitors for functional interference of different cells and for the treatment of immunological, inflammatory, neuronal and other diseases |
| 05/19/2005 | CA2544548A1 2-halogen-6-alkyl-phenyl-substituted tetramic acid derivatives |
| 05/19/2005 | CA2543882A1 Aralkyl amines as cannabinoid receptor modulators |